Home ›
Organizations ›
CANCER RESEARCH AND BIOSTATISTICS
CANCER RESEARCH AND BIOSTATISTICS
WA · Medical Research · EIN 911828539
27
Executives Disclosed
$11.3M
Annual Revenue
$9.9M
Total Assets
2.4:1
Internal Pay Ratio
CANCER RESEARCH AND BIOSTATISTICS has 27 executives with disclosed compensation. The highest-paid executive, Hoering Antje (PRESIDENT AND CEO), received peak total compensation of $464,367. The sector average for Medical Research executives is $311K.
Top Executive Compensation Over Time
Executive Compensation
| Name | Title | Peak Comp. | Latest Comp. | Years | vs. Household |
|---|---|---|---|---|---|
| Hoering Antje | PRESIDENT AND CEO | $464K | $464K | 2024–2024 | 6.2x |
| Antje Hoering | CEO & BOARD PRESIDENT | $431K | $417K | 2016–2023 | 5.7x |
| Keith W Goodman | VP, CHIEF TECHNOLOGY OFFICER | $296K | $296K | 2016–2022 | 3.9x |
| Curt Malloy | VP, COO & BOARD SECRETARY | $264K | $249K | 2017–2023 | 3.5x |
| Williams Charters | VP, CFO | $253K | $0 | 2017–2022 | 3.4x |
| William E Barlow | SENIOR BIOSTATISTICIAN | $241K | $163K | 2016–2023 | 3.2x |
| Mar Chong Damien | CFO, TREASURER | $239K | $239K | 2022–2024 | 3.2x |
| Cook Christopher | CTO, SECRETARY | $224K | $224K | 2024–2024 | 3x |
| Chris Cook | VP, CHIEF TECHNOLOGY OFFICER | $222K | $222K | 2022–2023 | 3x |
| Tammy Buist | VP, CHIEF BUS DEVELOPMENT OFFICER | $218K | $0 | 2016–2020 | 2.9x |
| Nishimura Katherine | SR. BIOSTATISTICIAN | $202K | $202K | 2024–2024 | 2.7x |
| Christopher J Cook | Director of Applications Dev. | $199K | $199K | 2016–2021 | 2.7x |
| William S Charters | Vice President/Chief Financial Officer | $196K | $196K | 2016–2016 | 2.6x |
| Patrick G Durham | DIRECTOR OF IT | $196K | $196K | 2016–2023 | 2.6x |
| Katherine K Nishimura | SENIOR BIOSTATISTICIAN | $193K | $193K | 2021–2023 | 2.6x |
| Durham Patrick | DIRECTOR INFORMATION SECURITY | $190K | $190K | 2024–2024 | 2.5x |
| Brian Miller | DIRECTOR OF FINANCE | $185K | $185K | 2016–2023 | 2.5x |
| Goren Emily | SR. BIOSTATISTICIAN | $180K | $180K | 2024–2024 | 2.4x |
| Lynn Shemanski | Senior Biostatistician | $178K | $178K | 2016–2016 | 2.4x |
| Godfrey Timothy | DIRECTOR APPLICATIONS DEVELOPMENT | $175K | $175K | 2024–2024 | 2.3x |
| Sutter Rodney | PROGRAM DIRECTOR THERAPEUTIC STUDIES | $169K | $169K | 2024–2024 | 2.3x |
| John J Crowley | DIRECTOR/CHIEF OF STRATEGIC ALLIANCES | $167K | $0 | 2016–2023 | 2.2x |
| Evonne M Lackey | 1st Vice President, Chief Data Mgmt | $164K | $164K | 2016–2016 | 2.2x |
| Rodney Sutter | PROGRAM DIRECTOR, THERAPEUTIC STUDIES | $161K | $161K | 2019–2023 | 2.1x |
| Terrence Lynch | SENIOR SYSTEMS ENGINEER | $141K | $0 | 2017–2018 | 1.9x |
| Malloy Curtis | COO, SECRETARY (UNTIL 4/12/24) | $114K | $0 | 2024–2024 | 1.5x |
| Crowley John | DIRECTOR, CHIEF OF STRATEGIC ALLIANCES | $88K | $0 | 2024–2024 | 1.2x |
Annual Summary
| Year | Executives | Avg. Comp. | Highest Comp. | Total Payroll |
|---|---|---|---|---|
| 2016 | 11 | $192K | $278K | $1.7M |
| 2017 | 11 | $210K | $312K | $1.5M |
| 2018 | 11 | $230K | $349K | $1.6M |
| 2019 | 11 | $223K | $366K | $2.0M |
| 2020 | 11 | $225K | $380K | $2.0M |
| 2021 | 10 | $225K | $400K | $2.0M |
| 2022 | 12 | $224K | $431K | $2.2M |
| 2023 | 10 | $222K | $417K | $2.0M |
| 2024 | 10 | $231K | $464K | $1.8M |
Email Alerts
Get notified about CANCER RESEARCH AND BIOSTATISTICS
Get an email when a new IRS Form 990 filing is posted that includes this organization. We send a confirmation link first - we don't add you to any other list.